Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis
Titel:
Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis
Auteur:
Park, Won Suh, Chang-Hee Shim, Seung Cheol Molina, Francisco Fidencio Cons Jeka, Slawomir Medina-Rodriguez, Francisco G. Hrycaj, Pawel Wiland, Piotr Lee, Eun Young Shesternya, Pavel Kovalenko, Volodymyr Myasoutova, Leysan Stanislav, Marina Radominski, Sebastiao Lim, Mie Jin Choe, Jung-Yoon Lee, Sang Joon Lee, Sung Young Kim, Sung Hwan Yoo, Dae Hyun